Celebrity duo bring sports flavor to the conversation about a serious men's health threat
CARY, N.C., Dec. 4 /PRNewswire/ -- College basketball analyst and sports ambassador Dick Vitale and co-host of ESPN's Pardon the InterruptionMichael Wilbon have teamed up with ESPN, The V Foundation for Cancer Research(R) and Stand Up To Cancer(TM) in an effort to create a national discussion about the often ignored reality of prostate cancer and to help men start to understand their potential risk for the disease. Prostate cancer is among the biggest men's health concerns. It currently affects approximately two million American men; more than 186,000 men will be diagnosed with prostate cancer in 2008 alone.
The effort launches with Life: Interrupted - Stand Up To Prostate Cancer, a town hall-style program taking place Thursday, December 4, at New York City's ESPNZone. The event will tackle prostate cancer, which affects 1 out of every 6 American men. This event signals the start of a robust collective fight to defeat prostate cancer by empowering men to take control of their prostate health.
"Last year, I had a prostate health scare. Luckily, I escaped a diagnosis of prostate cancer, but I've since realized I need to take control of my health, especially my prostate health," explained Vitale. "I've joined this cause because I want men to seize control of their health and take the necessary steps to help manage their prostate cancer risk. The disease causes so much of an interruption to a man's life, and the time has come to step up the fight against it."
Vitale and Wilbon are hosting the town hall, which will follow a sports show style format and will feature various sports and prostate cancer-relevant topics. This format engages men about their health within a dialogue of sports topics. Other panelists include one the nation's leading urologists, Dr. Steven Kaplan; Nick Valvano of The V Foundation; Dr. Jonathan Simons of the Prostate Cancer Foundation; Dr. Jean Bonhomme of the Men's Health Network as well as Ted Danson, DL Hughley and Joe Theismann.
"If the first time you think about prostate cancer is when you're diagnosed, it might be too late. Men over the age of 40, especially those with other risk factors, should be proactive in managing their prostate health," said Kaplan, M.D., F.A.C.S., Vice Chairman of the Department of Urology at
Dr. Kaplan, among the other panelists, will paint the picture of prostate cancer in America, showing why prostate cancer is such an interruption in men's lives. After all, every 2.5 minutes, a man is diagnosed with prostate cancer. And, every 19 minutes, a man dies from it.
"Dick and I wish that every guy out there could hear the message we are trying to spread," commented Wilbon. "The good news is that the show will be available as a podcast on www.JimmyV.org."
GlaxoSmithKline (GSK) proudly provided funding and support for the 'Life: Interrupted' initiative. GSK is closing in on cancer from all sides with a new generation of patient-focused cancer treatments in prevention, supportive care, chemotherapy and targeted therapies. Just one example of this commitment: GSK has invested significant resources in prostate cancer prevention research. GSK also is a major supporter of Stand Up To Cancer and its innovative research-support efforts.
Additional supporters and in attendance at the 'Life: Interrupted' town hall event include the American Urological Association Foundation, CancerCare, Men's Health Network, Prevent Cancer Foundation, Prostate Cancer Education Council, Prostate Cancer Foundation, UsTOO International Prostate Cancer Education & Support Network, Women Against Prostate Cancer, and ZERO - The Project to End Prostate Cancer.
About The V Foundation
The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary
About Stand Up to Cancer (SU2C)
Stand Up To Cancer is a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, and was established by a group of media, entertainment and philanthropic leaders, whose lives have all been affected by cancer in significant ways.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2007.
|SOURCE The V Foundation|
Copyright©2008 PR Newswire.
All rights reserved